Publication Name	World Journal of Clinical Cases
Manuscript ID	60323
Country	China

Received	2020-10-30 03:16
Peer-Review Started	2020-10-30 03:17
To Make the First Decision
Return for Revision	2020-11-20 05:06
Revised	2020-12-04 10:45
Second Decision	2020-12-14 12:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-12-16 20:03
Articles in Press	2020-12-16 20:03
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-01-01 22:56
Typeset the Manuscript	2021-01-25 02:59
Publish the Manuscript Online	2021-01-30 10:10

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Venetoclax in combination with chidamide and dexamethasone in relapsed/refractory primary plasma cell leukemia without t(11;14): A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Yang Yang, Li-Juan Fu, Chun-Mei Chen and Mei-Wei Hu
ORCID	Author(s) ORCID Number Yang Yang http://orcid.org/0000-0001-7110-4462 Li-Juan Fu http://orcid.org/0000-0002-6033-0883 Chun-Mei Chen http://orcid.org/0000-0002-6765-061X Mei-Wei Hu http://orcid.org/0000-0001-8853-7651
Funding Agency and Grant Number
Corresponding Author	Mei-Wei Hu, MSc, Associate Chief Physician, Department of Hematology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, No. 318 Chaowang Road, Hangzhou 310014, Zhejiang Province, China. humweiwei@sina.cn
Key Words	Relapsed/refractory; Primary plasma cell leukemia; Venetoclax; Chidamide; Very good partial response; Case report
Core Tip	Primary plasma cell leukemia (pPCL) is a rare and high mortality disease. We herein described a case report of a relapsed/refractory pPCL without t(11;14) who achieved a very good partial response from venetoclax therapy in combination with chidamide and dexamethasone.
Publish Date	2021-01-30 10:10
Citation	Yang Y, Fu LJ, Chen CM, Hu MW. Venetoclax in combination with chidamide and dexamethasone in relapsed/refractory primary plasma cell leukemia without t(11;14) A case report. World J Clin Cases 2021; 9(5): 1175-1183
URL	https://www.wjgnet.com/2307-8960/full/v9/i5/1175.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i5.1175

Full Article (PDF)	WJCC-9-1175.pdf
Full Article (Word)	WJCC-9-1175.docx
CARE Checklist–2016	60323-CARE-Checklist–2016-revision.pdf
Manuscript File	60323-Review-FilipodiaCL.docx
Answering Reviewers	60323-Answering reviewers.pdf
Audio Core Tip	60323-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	60323-Conflict-of-interest statement.pdf
Copyright License Agreement	60323-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	60323-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	60323-Language certificate.pdf
Peer-review Report	60323-Peer-review(s).pdf
Scientific Misconduct Check	60323-Bing-Wang JL-1.jpg
Scientific Misconduct Check	60323-Bing-Chen XF-2.png
Scientific Misconduct Check	60323-Scientific misconduct check.pdf
Scientific Editor Work List	60323-Scientific editor work list.pdf